Paratek Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Paratek Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Paratek Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Paratek Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Paratek Pharmaceuticals Inc (Paratek) is a biopharmaceutical company. Its lead product candidate, Nuzyra, existing collaborations, and focus on research and development are its strengths, even as reliance on a single product is a cause of concern. Whereas the company could benefit from the positive outlook of the global pharmaceutical market, the market potential of Omadacycline, and the fast-track designation. However, stiff competition, pricing pressure, and industry regulation could hamper the company's business operations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer